Novartis Drug Data Allegations Revive Questions Over Ethics August 7, 2019 By Michelle Fay Cortez, Anna Edney and James Paton Concern over Novartis AG’s corporate culture returned to the spotlight after U.S. regulators said the Swiss drugmaker delayed disclosing manipulation...
